Sort
50,496 grants matching “lung cancer”
A Randomized Trial to Minimize Non-Response to Aerobic Training in Operable Breast Cancer
$620,371Jessica Scott · Sloan-Kettering Inst Can Research · R37 · FY2024 · CA
Optimizing Individualized and Adaptive mHealth Interventions via Control Systems Engineering Methods
$620,335Eric Hekler · University Of California, San Diego · R01 · FY2022 · CA
Molecular Epidemiology of Secondary Lung Cancer
$620,322Georgetown University · R01 · FY2005 · CA
Accurate MR-based PET Attenuation Correction for Quantitative Clinical Trials
$620,305Raymond F Muzic · Case Western Reserve University · R01 · FY2015 · CA
Caregiver Coping Skills training for Lung Cancer
$620,301Duke University · R01 · FY2002 · CA
Therapeutic approaches for LKB1-deficient non-small cell lung cancer
$620,252John V. Heymach · University Of Tx Md Anderson Can Ctr · R01 · FY2016 · CA
Evaluating the implementation and impact of navigator-delivered ePRO home symptom monitoring and management
$620,129Gabrielle Rocque · University Of Alabama At Birmingham · R01 · FY2022 · NR
Therapeutic Targeting of NSD2 in Lung Adenocarcinoma
$620,060Pawel K. Mazur · University Of Tx Md Anderson Can Ctr · R01 · FY2024 · CA
ECM geometrical and mechanical properties modulate RTK signaling
$620,054Jay T. Groves · University Of California Berkeley · U01 · FY2019 · CA
CAREER: Modulating Local Tumor Hypoxia using Cryogel Scaffolds to Regulate Dendritic Cell Function and Activity
$620,046Sidi A Bencherif · Northeastern University · · FY2019 · MPS
VASCULAR, PULMONARY AND RENAL INJURY
$620,017Michael A Gimbrone · Brigham And Women'S Hospital · T32 · FY2008 · HL
Nanotechnology Platform for Targeting Solid Tumors
$619,999Sidney Kimmel Cancer Center · R01 · FY2005 · CA
Novel Radiomics for Predicting Response to Immunotherapy for Lung Cancer
$619,994Anant Madabhushi · Case Western Reserve University · R01 · FY2021 · CA
CB: Administration, Evaluation, and Planning
$619,944Bruce D Johnson · Dana-Farber Cancer Inst · P50 · FY2012 · CA
Programmable encapsulation systems to improve delivery of therapeutic bacteria
$619,930Tal Danino · Columbia Univ New York Morningside · R01 · FY2025 · EB
Using patient-derived models to understand drug responses in SCLC
$619,923Nicholas J Dyson · Massachusetts General Hospital · U01 · FY2020 · CA
Using patient-derived models to understand drug responses in SCLC
$619,923Nicholas J Dyson · Massachusetts General Hospital · U01 · FY2018 · CA
Randomized Trial of Automated Video-Assisted Smoking Treatment for People Living with HIV
$619,902Damon J. Vidrine · H. Lee Moffitt Cancer Ctr & Res Inst · R01 · FY2023 · CA
Translation of a Bismuth-Gadolinium Nanoparticle for MR-guided Radiation Therapy
$619,902Ross I. Berbeco · Dana-Farber Cancer Inst · R01 · FY2020 · CA
Multiscale modeling of the battle over iron in invasive lung infection
$619,827Reinhard Laubenbacher · University Of Connecticut Sch Of Med/Dnt · R01 · FY2018 · AI
Chronic Exposure to House Dust Mites: A New Risk Factor for Lung Cancer in Never Smokers
$619,804Eyal Raz · University Of California, San Diego · U01 · FY2025 · CA
Hybrid Trial of a Tailored Smoking Cessation Digital Therapeutic for Persons Living with HIV
$619,707Roger Vilardaga · Wake Forest University Health Sciences · R01 · FY2025 · CA
Chemoprevention of lung cancer with mitochondria-targeted honokiol
$619,654Ming You · Medical College Of Wisconsin · R01 · FY2019 · CA
Determinants of acquired resistance in small cell lung cancer
$619,653Charles M Rudin · Sloan-Kettering Inst Can Research · R01 · FY2017 · CA
Determinants of acquired resistance in small cell lung cancer
$619,653Charles M Rudin · Sloan-Kettering Inst Can Research · R01 · FY2018 · CA